| Financial Year |
March 31 2023 |
| Monetary Funds |
1,523,044,717.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,611,366,239.21 |
| Advances to Suppliers |
84,356,972.12 |
| Other Receivables |
28,428,261.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,805,632.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,521,252.59 |
| Total Current Assets |
3,689,097,676.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,187,108.32 |
| Investment Properties |
-- |
| Fixed Assetes |
110,844,383.45 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,501,546.35 |
| R&D expenses |
-- |
| Goodwill |
123,454,402.70 |
| Long-Term Deferred and Prepaid Expenses |
3,169,875.46 |
| Deferred Income Tax Assets |
30,281,108.23 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
409,920,116.80 |
| Total Assets |
4,099,017,793.67 |
| Short-Term Loans |
453,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,069,898.00 |
| Accounts Payable |
8,071,122.87 |
| Accounts Received In Advance |
7,528.00 |
| Employee Compensation Payable |
133,073,187.00 |
| Taxes Payable |
123,240,781.12 |
| Interest Payable |
72,123.29 |
| Dividend Payable |
-- |
| Other payables |
9,232,628.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,947,447.78 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
747,059,385.76 |
| Long-term Loans |
-- |
| Bonds Payable |
712,503,542.09 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,550,784.93 |
| Other Non-Current Liabilities |
784,022.80 |
| Sub-Total of Non-Current Liabilities |
741,302,689.12 |
| Total Liabilities |
1,488,362,074.88 |
| Paid-In Capital(Or Share Stock) |
404,427,654.00 |
| Capital Surplus |
1,367,339,510.50 |
| Surplus Reserve |
46,739,959.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
560,638,879.09 |
| Minority Stockholder's Interest |
2,350,666.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,608,305,051.83 |
| Owner's Equity（Stockholder's Equity） |
2,610,655,718.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,099,017,793.67 |
